Transforming growth factor b1 (TGF b1) is a wellcharacterized cytokine that suppresses epithelial cell growth. We report here that TGF b1 arrested lung epithelial Mv1Lu cells at G1 phase of the cell cycle with acquisition of senescent phenotypes in the presence of 10% serum, whereas it gradually induced apoptosis with lower concentrations of serum. The senescent arrest was accompanied by prolonged generation of reactive oxygen species (ROS) and persistent disruption of mitochondrial membrane potential (DWm). We demonstrated that the sustained ROS overproduction was derived from mitochondrial respiratory defect via decreased complex IV activity and was involved in the arrest. Moreover, we verified that hepatocyte growth factor released Mv1Lu cells from the arrest by protecting mitochondrial respiration, thereby preventing both the DWm disruption and the ROS generation. Our present results suggest the TGF b1-induced senescent arrest as another plausible mechanism to suppress cellular growth in vivo and provide a new biochemical association between the mitochondrial functional defects and the cytokine-induced senescent arrest, emphasizing the importance of maintenance of mitochondrial function in cellular protection from the arrest.
Introduction
Cellular senescence has been suggested to be an important process in two distinct phenomena: in aging and carcinogenesis (Mathon and Lloyd, 2001; Shay and Roninson, 2004) , which is not only due to its general effect of growth arrest but also by sharing common mechanisms involved. One of the prominent mechanisms explaining cellular senescence is cumulative irreversible damages caused by toxic oxygen intermediates, the so-called reactive oxygen species (ROS) (Ames et al., 1993; Beckman and Ames, 1998; Finkel and Holbrook, 2000) . Since oxygen is continuously utilized in aerobically growing cells, production of ROS, a major byproduct of oxygen-derived reaction, is inevitable. Among the several intracellular oxygen-utilizing systems, mitochondrial respiratory chain reaction is the major site, utilizing 85-90% of oxygen consumed by the cell, to generate the cellular energy needed for cellular growth. Moreover, the mitochondrial DNA is highly vulnerable to oxidative damage due to its proximity to the ROS generation site and its naked structure. Therefore, mitochondrial respiration is more prone to be damaged by ROS produced within their compartment, and consequently the damaged mitochondria release more ROS in a motion of vicious cycle, which has been a generally accepted theory of cellular aging (Sohal et al., 1994; Boveris and Costa, 1999; Raha and Robinson, 2000; Lee and Wei, 2001) .
Although the generation of mitochondrial ROS has long been implicated in the aging process, several recent studies have demonstrated that a moderate and sustained ROS produced by the activated stress signaling pathways, including Ras/MAPK (Lee et al., 1999) , phosphoinositide 3-kinase (PI3K)/Akt (Collado et al., 2000) , NF-kB (Supakar et al., 1995; Poynter and Daynes, 1998) , p53 (Macip et al., 2003) , p21 (Macip et al., 2002) , and p16
INK4a (Schmitt et al., 2000) , can also trigger the senescence program (Bringold and Serrano, 2000) . Modulation of the pathways is not unique to oxidative stress, but also plays central roles in controlling normal growth through regulating metabolic signaling (Cooper et al., 1983; Whiteman et al., 2002) . However, the mechanism of how the mitochondrial metabolic function is involved in the stress signalingmediated senescence has not yet been studied.
The stress signaling pathways can generally be activated by various environmental stimuli, including cytokines, UV irradiation, and chemotherapeutic agents (Finkel and Holbrook, 2000) . Transforming growth factor b1 (TGF b1) is a multifunctional cytokine that controls proliferation, differentiation, migration, and apoptosis of various cell types (Massague, 1998; Massague et al., 2000; Derynck and Zhang, 2003) . The involvement of TGF b1 in the aging and senescent process has recently been demonstrated by its direct induction of cellular senescence in a few cell lines, such as human diploid fibroblasts, mammary epithelial cells, and lung carcinoma cells (Kordon et al., 1995; Katakura et al., 1999; Frippiat et al., 2001) , in addition to its overexpression in aged animal (Zhao et al., 2002) and oxidatively stressed cells (Frippiat et al., 2001; Yoon et al., 2002) . Although the potential role of p27, p15, and p21 (Li et al., 1995; Katakura et al., 1999; Warner et al., 1999; Massague et al., 2000) or overproduction of ROS (Sanchez et al., 1996; Islam et al., 1997; Herrera et al., 2001) has been alluded in the TGF b1-induced senescence, the detailed underlying mechanisms remain unclear. In the present study, we show the importance of the presence of serum in inducing senescence-associated arrest of Mv1Lu lung epithelial cells by TGF b1 and the intimate association of mitochondrial metabolic function with the senescent arrest, which is involved in persistent generation of mitochondrial ROS. Finally, we also demonstrate that hepatocyte growth factor (HGF) could reverse the senescent arrest by protecting the mitochondrial function.
Results

TGF b1-induced senescence-associated G1 arrest of Mv1Lu cells depends on the presence of fetal bovine serum (FBS)
Mv1Lu cells exhibit one of the best-characterized antimitogenic responses to TGF b1 (Warner et al., 1999) . It has generally been accepted that the growth of Mv1Lu cells is prone to be arrested and finally committed to apoptosis when exposed to TGF b1 in serum-free media (Parekh et al., 1998) ; nevertheless, the growth arrest by TGF b1 has also been demonstrated even in the presence of 10% serum (Laiho et al., 1990; Taipale and Keski-Oja, 1996) . To assess the effect of FBS on the growth arrest induced by TGF b1, TGF b1 was applied in the presence of various concentrations of FBS. TGF b1 induced most of the cells to apoptosis with serum concentration lower than 2%, evidenced by trypan blue-stained dead cells, sub-G1 population after propidium iodide (PI) staining, and even by cleavage of poly (ADP-ribose) polymerase (PARP). However, when treated with TGF b1 in media containing higher than 2% FBS concentration, the apoptotic dead cells gradually decreased (Figure 1a-c) .
In order to ascertain the effect of TGF b1 on cellular destination in the presence of higher concentration of serum, we continuously cultured the cells in the medium containing TGF b1 (2 ng/ml) and 10% FBS. Interestingly, we observed progressive change of cellular morphology from the second day to an enlarged and flattened form, which is quite different from that with lower concentration of serum and is one of the typical characteristics of cellular senescence. By confirming the appearance of senescence-associated b galactosidase (SA-b-gal) activity and increase of cellular granularity, both of which are generally accepted senescent markers (Dimri et al., 1995; Chang et al., 1999) , the arrest was proved to be associated with cellular senescence (Figure  1d and e). The senescent phenotype by TGF b1 developed in dose-and time-dependent manners (Table 1) , and was accompanied by delayed growth rate with G1 arrest as expected (Supplementary Figure 1) . We also found that the senescent arrest was also developed by TGF b1 in WI 26 cell, an immortalized human lung epithelial cell line; however, it was observed only with media containing low serum level (0.5%) ( Supplementary Figure 2a and 
b).
Prolonged ROS generation and maintenance of mitochondrial integrity during TGF b1-induced senescence-like growth arrest It has long been hypothesized that mitochondrial defect and its resultant oxidative stress play a key role in the Mv1Lu cells were treated with 2 ng/ml TGF b1 in DMEM containing 10% FBS for the periods indicated. Then, the cells were analysed for cellular granularity (d) and stained for SA-b-gal activities (e) as described in Materials and methods cellular aging process (Sastre et al., 1999) . Therefore, we questioned whether and how mitochondrial defect and ROS generation were involved in the senescent arrest induced by TGF b1. First, we monitored mitochondrial membrane potential (DCm) by staining the cells with 5,5 0 ,6,6 0 -tetrachloro-1,1 0 ,3,3 0 -tetra-thylbenzimidazole carbocyanide iodide (JC-1) fluorescence dye. With increase of exposure time to TGF b1, green fluorescence-stained cells, which represented the cells harboring inactive mitochondria with low DCm, gradually increased and the degree of DCm disruption reached a maximum on day 3 (Figure 2a and Supplementary  Figure 3 ). When monitored with 2 0 ,7 0 -dichlorodihydrofluorescein (DCF) fluorescence (Figure 2b ), persistent increase of intracellular ROS level was observed until the third day and sustained thereafter. The ROS increase was confirmed with dihydrorhodamine 123 (DHR123), a dye known to capture mitochondrial ROS, implying that ROS might be generated from mitochondria ( Figure 2c ). Interestingly, despite the DCm disruption and enhanced ROS production, any apoptogenic factors such as cytochrome c, AIF, or smac was not released from the mitochondria, implying that the integrity of mitochondrial outer membrane was intact and, consequently, apoptogenic signaling from mitochondria was prevented (Figure 2d ).
The DCm disruption and ROS increase were also found in TGF b1-induced senescent arrested WI26 cells ( Supplementary Figure 2c and d) . We then examined whether these phenomena were truly mediated through TGF b1-type I receptor signaling. When TGF b1 (2 ng/ml) was applied to R1B cells (type I receptor-null Mv1Lu mutant cells), neither DCm disruption and ROS production nor even senescent phenotype was observed (data not shown).
The increased ROS level resulted from defective mitochondrial respiration and was involved in the acquisition of the senescent phenotype To explore the relationship between the ROS production and DCm disruption, we first examined the effect of antioxidants, N-acetylcysteine (NAC) and 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox), on ROS overproduction and DCm disruption. Pretreatment of the cells with 100 mM Trolox or 5 mM NAC could sufficiently eliminate the ROS generated by TGF b1, but not ameliorate the disrupted DCm (Figure 3 ), implying that the ROS generation and DCm disruption were independent of each other, or ROS might be generated by defective mitochondrial function. Since mitochondrial respiratory complexes have long been considered as one of the main sources of ROS generation, to assess the hypothesis, we employed specific inhibitors of mitochondrial oxidative phosphor- ylation. When 2 mM KCN (a complex IV inhibitor) or 2 mM oligomycin (a complex V inhibitor) was applied to the cells exposed to TGF b1, ROS generation was completely blocked (Figure 4a ). On the other hand, the TGF b1-induced ROS generation was not blocked by DPI (an inhibitor of NADPH oxidase) and was only slightly reduced by 2-(12-hydroxydodeca-5,10-diynyl)-3,5,6-trimethyl-p-benzoquinone (AA861; 5-lipoxygenase inhibitor) (Figure 4b ), leading to the conclusion that the continually overproduced ROS by TGF b1 was mainly derived from the mitochondrial respiratory chain. To further elucidate whether TGF b1 really affected mitochondrial respiration, we monitored the cellular O 2 consumption rate. As shown in Figure 4c , 2,4-dinitrophenol (DNP)-uncoupled cellular respiration rate decreased upon treatment of TGF b1 in a timedependent manner. Transient treatment of Mv1Lu cells with H 2 O 2 (0.8 or 1 mM) for 2 h was enough to destine the cells to senescence, demonstrating that Mv1Lu cells exposed to an increased intracellular ROS level caused by TGF b1 were susceptible to develop senescence (Supplementary Figure 4) . Moreover, the TGF b1-induced senescent phenotype was reversed by removal of ROS with pretreatment of 5 mM NAC (Figures 3a and 5) , strongly implying the crucial role of ROS in the arrest.
The defective mitochondrial respiration was associated with decreased complex IV activity How could mitochondrial respiration be decreased? In order to answer this question, we monitored the activities of mitochondrial respiratory chain complexes. There were no significant changes observed in the complex I/III-coupled activity (NADH-cytochrome c reductase activity) and complex II/III-coupled activity (succinate-cytochrome c reductase), implying that all the complex I, II, and III activities are intact (Figure 6a and  b) . Furthermore, complex IV activity was estimated by its oxidizing capacity of reduced cytochrome c spectrophotometrically and complex IV-derived O 2 consumption rate (Figure 6c and d) . When the cells were treated with TGF b1, the complex IV activity was significantly decreased, suggesting that the defective mitochondrial respiration might have been primarily due to the decreased complex IV activity.
Employing KCN, a complex IV activity inhibitor, we next addressed whether the decrease in the complex IV activity could be the cause of the ROS production. With the concentrations of KCN, at which cellular respiration was partially or completely inhibited, ROS was significantly generated (Figure 7 ).
HGF reversed TGF b1-induced senescence-associated arrest by protecting mitochondrial function Recently, several reports described the reciprocal effect of HGF on TGF b1-induced growth arrest of epithelial cells (Taipale and Keski-Oja, 1996; Tsubari et al., 1999) ; however, its effect on senescent arrest has not been well documented. In our study, simultaneous treatment of HGF together with TGF b1 could clearly reverse the senescent phenotypes, which was evidenced by SA-b-gal activity (Table 1) .
Finally, we examined the effect of HGF on mitochondrial function. As shown in Figure 8 , HGF protected mitochondrial respiratory function from TGF b1- The prolonged ROS generation mainly originated from defective mitochondrial respiration. TGF b1-treated cells for 3 days were further incubated with KCN (2 mM) or oligomycin (2 mM) for 3 h, and then ROS levels were measured using DCFH-DA (a). DPI (5 mM) or AA861(10 mM) was applied for 1 h after 3-day treatment with TGF b1 and then ROS level was measured (b). After exposure to TGF b1 for the times indicated, maximum cellular respiration rates were determined as a DNP-coupled vs KCN-inhibited O 2 consumption rate, and expressed as percentage of control (inset) as described in Materials and methods (c) induced damage, maintained DCm, and prevented the mitochondrial ROS overproduction.
Discussion
TGF b1 is one of the best-known cytokines that suppresses proliferation and induces apoptosis in several epithelial cells, playing its role as a tumor suppressor.
Although the apoptotic effect of TGF b1 in the absence of serum has widely been studied, its effect of growth arrest and the underlying mechanism in the presence of serum remained unclear, which might be more important in vivo. In our present study, we found that Mv1Lu lung epithelial cells underwent apoptosis, when treated with TGF b1 in the presence of low serum concentration (below 2% FBS), but the cells were progressively destined to senescence-associated arrest in higher concentration of FBS (Figure 1 ). These results implied that blocking apoptotic signaling might be a prerequisite for transition from apoptosis to senescence and can be accomplished by a certain concentration of some factors in FBS, and further supported the report that the senescent cells are resistant to apoptotic cell death (Suh et al., 2002) due to their acquired defensive power. Several studies have shown that TGF b1 triggers not only apoptosis but also transdifferentiation of several epithelial cells to fibroblasts, termed epithelial-to-mesenchymal transdifferentiation (EMT) (Bhowmick et al., 2001; Ellenrieder et al., 2001) . Moreover, it has been reported recently that TGF b cytokines induce SA-b-gal activity in human prostate basal cells by supporting differentiation processes, but not cellular senescence (Untergasser et al., 2003) . Therefore, we also attempted to elucidate whether the phenotypes observed were parts of EMT, by examining the induction of vimentin as a marker for mesenchymal transdifferentiation. However, no induction of vimentin expression was found (data not shown), implying that the phenotypes by TGF b1 in our system were specific to senescence-associated arrest. Recently, the direct involvement of TGF b1 in cellular senescence has also been implicated using human diploid fibroblasts (Kordon et al., 1995) and human lung carcinoma cell, A549 (Katakura et al., 1999) , but the underlying mechanisms are not clearly understood. The senescent process by TGF b1 could simply be predicted to be due to its known potential to induce oxidative stress (Sanchez et al., 1996; Islam et al., 1997; Herrera et al., 2001) , when keeping in mind the importance of the oxidative stress in cellular senescence. However, the involvement of ROS and/or the site of its production in the TGF b1-induced senescent process have not been clearly elucidated. Moreover, no clear relevance of the TGF b1-induced oxidative stress and the mitochondrial defect, which is the crux of oxidative stress in aging, has been revealed. Our observation on the prolonged generation of ROS and concurrent DCm disruption (Figure 2 ) strongly suggested intimate association between oxidative stress and mitochondrial defect. To date, NAD(P)H oxidase was the only site identified to transiently generate ROS in the early phase in TGF b1-treated fibroblast (Thannickal and Fanburg, 1995) , and we could also detect early transient ROS production within 12 h and ROS could partially be removed by treatment of DPI in our system (Supplementary Figure 5 ), implying that ROS was generated by the combined action of NADPH oxidase and a hitherto-unidentified other oxygen-derived reaction. However, the removal of the early ROS by pretreatment with NAC or Trolox could not ameliorate the DCm disruption (Figure 3) , indicating that the initial ROS did not affect the DCm and also suggesting that the late prolonged ROS overproduction might be due to the DCm disruption. By employing mitochondrial inhibitors such as KCN and oligomycin, and by measuring the cellular respiration rate (Figure 4) , we proved that the second prolonged ROS increase was really generated from the defective mitochondrial respiratory reaction.
ROS production and consequent oxidative stress have long been implicated in aging and senescence. Direct involvement of ROS overproduction was also demonstrated in our system, evidenced by direct induction of senescence by exogenous H 2 O 2 (Supplementary Figure  4) and reversal of the arrest by pretreatment of NAC ( Figure 5) . Recently, the involvement of p21
Cip1 has been emphasized in ROS accumulation associated with senescence (Macip et al., 2002) . In addition to its key role in TGF b1-induced growth arrest together with p27
Kip1 (Massague et al., 2000) , we therefore examined the possibility of whether p21
Cip1 was involved in the TGF b1-induced ROS generation. Under the TGF b1-induced senescent process in Mv1Lu cells, p27
Kip1 was induced for up to 12 h and thereafter decreased, whereas p21
Cip1 was slowly and continuously induced until the third day. The p21 Cip1 induction was blocked by NAC pretreatment and p21
Cip1 could also be induced by treatment of exogenous H 2 O 2 . These data implied that p21 Cip1 might be induced as a result of ROS production and plays an alternative role for p27
Kip1 in the late stage of the arrest (Supplementary Figure 6) .
The fact that the complex IV activity among the four respiratory complexes specifically decreased upon treatment of TGF b1 strongly implies that the mitochondrial respiratory defect might be due to decreased complex IV activity (Figure 6 ). Is it possible to generate ROS from defective complex IV activity? Among the four mitochondrial respiratory complexes, complex IV has been well known as the only complex where no quinonemediated electron transfer reaction is involved and no superoxide is generated due to its complete reduction of O 2 molecule to H 2 O. Therefore, we examined a possibility of whether inhibition of complex IV activity could be involved in the mitochondrial ROS production by employing KCN, an inhibitor of complex IV activity, and showed that ROS could also be overproduced by partial inhibition of complex IV activity (Figure 7) . A more detailed mechanism of how TGF b1 could decrease complex IV activity is currently under investigation.
Several studies have recently demonstrated that the growth arrest induced by TGF b1 was reversed by HGF, a mesenchymal cell-derived cytokine, which has mitogenic, motogenic, and morphogenic property for epithelial cells (Taipale and Keski-Oja, 1996; Tsubari et al., 1999) . In our present study, we further found that HGF could not only reverse the TGF b1-induced apoptosis in the low serum concentration (data not shown), but also the senescent arrest with high serum concentration (Table 1) . Furthermore, we demonstrated that the reversal by HGF was accomplished through protection of mitochondrial respiratory function, and that overproduction of mitochondrial ROS was consequently blocked (Figure 8 ), implicating the potential role of HGF in maintenance of mitochondrial respiratory function for optimal cellular growth.
Taken altogether, our data clearly exhibit that TGF b1 does not induce apoptosis, but senescent arrest in the presence of serum, implying that the senescent arrest induced by TGF b1 might be a new plausible mechanism to suppress cellular growth due to the ubiquitous presence of serum in vivo. Moreover, our study further demonstrates the biochemical relationship between mitochondrial functional defects and cellular commitment to the senescent arrest induced by TGF b1, a single cytokine, and emphasizes the importance of maintenance of mitochondrial function in cellular protection against the senescent arrest.
Materials and methods
Cell culture, growth rates, and viability Mv1Lu cells were cultured in Dulbecco's modified Eagle's medium (DMEM) (Gibco BRL, MD, USA) and 10% FBS (Gibco BRL) in a 371C incubator with 5% CO 2 in air and treated with 2 ng/ml TGF b1, unless indicated otherwise. Cellular growth rates of TGF b1-and/or HGF-treated Mv1Lu cells were monitored by counting the viable cells. Briefly, 1 Â 10 3 cells were seeded into 24-well plates, cultured in DMEM containing 10% FBS for 12 h, and treated with TGF b1 (2 ng/ml) and/or HGF (20 ng/ml) for the indicated periods. The cells were continuously cultured by refreshing every 3 days with the media containing the same growth factors, if necessary. At the indicated times, cells were harvested by trypsinization and counted with a hemocytometer after staining with 0.4% (w/v) trypan blue (Gibco BRL) to exclude dead cells. To evaluate cellular viability, the population of trypan blue-stained dead cells were counted and represented as the percent of total cells.
Reagents and antibodies
Recombinant TGF b1 and HGF were obtained from R&D systems (Minneapolis, MN, USA). 5,5
0 ,6,6 0 -tetrachloro-1,1 0 ,3,3 0 -tetra-thylbenzimidazole carbocyanide iodide (JC-1), DCFH-DA, and DHR123 were purchased from Molecular probe Corp. (Eugene, OR, USA). NADH, cytochrome c, antimycin A, DNP, DPI, and tetramethyl-p-phenylene diamine (TMPD) were from Sigma-Aldrich (St Louis, MO, USA). Trolox and AA861 were purchased from BioMol Research Laboratory (Plymouth Meeting, PA, USA).
The antibody against cytochrome c (556433) was purchased from BD Pharmingen (San Diego, CA, USA), and the antibody against Fp protein of complex II (A11142) was from Molecular Probe Corp. PARP antibody was obtained from Zymed Laboratories Inc. (South San Francisco, USA), MnSOD antibody was from Stressgen (Victoria, Britich Columbia, Canada), and tubulin (Ab-1) and smac (Ab-3) antibodies were from Oncogene (Boston, MA, USA).
Cell cycle analysis and senescence-associated b-galactosidase assay Cell cycle analysis was performed by PI staining according to the protocol provided with CycleTESTt PLUS DNA reagent kit (Becton Dickinson, Ontario, Canada). SA-b-gal was assayed at pH 6.0 as described by Dimri et al. (1995) with a slight modification (Yoon et al., 2002) .
Mitochondrial transmembrane potential (DCm)
DCm was estimated by staining cells with JC-1 (Molecular probe) fluorescence dye. To assess the DCm changes of cells exposed to TGF b1, cells were incubated for 1 h with 10 mg/ml JC-1, washed with PBS (137 mM NaCl, 2.7 mM KCl, 10 mM phosphate buffer, pH 7.4), and finally visualized by Fluoromicroscope (Diaphot 300, Nikon, Japan). To quantitate the degree of disrupted DCm, cells stained with JC-1 were collected by trypsinization and resuspended in PBS, and green fluorescences of the cells were analysed by flow cytometry (FACS Vantage, Becton Dickinson Corp.) . The intensity of the green fluorescence was considered as a degree of DCm disruption.
Determination of intracellular ROS level and granularity
To determine the intracellular level of ROS, we used two different fluorogenic probes: DCFH-DA and DHR123 (Molecular probe). Cells were treated with TGF b1 for the indicated periods and further incubated in media containing 10 mM DCFH-DA or DHR123 for 15 min at 371C. Cellular granularity was evaluated by analysing side scatter of the DCFH-DA-stained cells using flow cytometry.
Mitochondrial fractionation for detection of mitochondrial apoptogenic factors Cells (5 Â 10 6 ) were washed with PBS, harvested by trypsinization, and resuspended in medium A (250 mM sucrose, 0.1 mM EDTA, 2 mM HEPES, pH 7.4). The cell slurry was homogenized in a Dounce homogenizer (StedFastt Stirrer, Fisher Scientific, Pittsburgh, PA, USA), followed by spin at 580 g for 10 min to remove nuclei and cell debris. The supernatant was further centrifuged at 14 300 g for 10 min. The final supernatant (crude cytosolic fraction) and the pellet (mitochondrial fraction) were lysed in lysis buffer (50 mM Tris-HCl, pH 7.5, 0.1 M NaCl, 1 mM EDTA, 1% (w/v) Triton X-100, 10 mg/ml each of aprotinin and leupeptin, and 1 mM PMSF) before being subjected to Western blot analysis for detection of smac, AIF, and cytochrome c.
Endogenous cellular oxygen consumption
Endogenous cellular respiration was measured as described previously (Villani and Attardi, 2001 ) with slight modification (Yoon et al., 2003) . Briefly, exponentially growing Mv1Lu cells (5 Â 10 6 ) were cultured in the absence or presence of TGF b1, washed with TD buffer (0.137 M NaCl, 5 mM KCl, 0.7 mM Na 2 HPO 4 , 25mM Tris-HCl, pH 7.4), and collected by trypsinization. After resuspending the cells in 0.3 ml of complete medium without phenol red, the cells were transferred to the chamber of Mitocell equipped with Clark oxygen electrode (782 Oxygen Meter, Strathkelvin Instrument, Glasgow, UK). Oxygen consumption rates were measured after adding 30 mM DNP to obtain maximum respiration rate and its specificity for mitochondrial respiration was confirmed by adding 10 mM KCN. Maximum cellular respiration rates are expressed as the ratio of DNP-uncoupled O 2 consumption rate vs KCN-inhibited O 2 consumption rate.
Assays for mitochondrial respiratory chain activities
The integrated activities of complex I and III, and complex II and III in the cell lysate, were measured as described previously (Esposti, 2001 ) with slight modification (Yoon et al., 2003) . Complex IV activity was determined as described (Birch-Machin and Turnbull, 2001 ) with slight modification, by measuring the capacity to oxidize reduced cytochrome c at 550 nm. To prepare reduced cytochrome c, 1 mM of cytochrome c was reduced by adding a few crystals of sodium hydrosulfite (Na 2 S 2 O 4 ) and incubated at 251C for 5 min, and then the reduced cytochrome c was purified by Sephadex G-50 chromatography. To determine complex IV activity, cells were lysed in PES buffer and further incubated with 1 mg/ml of ndodecylmaltoside for 20 min on ice. The initial rate of oxidizing the reduced cytochrome c was monitored spectrophotometrically (Ultrospec 3000) at 550 nm in the reaction mixture (20 mM potassium phosphate, pH 7.4, 100 mM reduced cytochrome c) in the presence of 200 mM antimycin A. The reaction was started by the addition of the n-dodecylmaltosidetreated cell lysates (30 mg) and a rapid mix to detect the KCNsensitive initial rate. Complex IV activity was also determined by monitoring KCN-sensitive complex IV-dependent O 2 consumption rate, which was obtained by measuring O 2 consumption rate in the presence of 3 mM TMPD under the treatment of 30 mM DNP and 20 mM antimycin A and expressed as a percentage of TMPD-activated vs KCNinhibited activity.
Western blot analysis
Cells were washed twice with PBS and lysed with lysis buffer (50 mM Tris-HCl, pH 7.5, 0.1 M NaCl, 1 mM EDTA, 1% Triton X-100, 10 mg/ml each of aprotinin and leupeptin, and 1 mM PMSF). A portion (40 mg) of lysate was electrophoresed on SDS-polyacrylamide gel. The proteins were electrically transferred onto nitrocellulose membrane (Protran, S&S Inc., NH, USA) and subjected to immunoblot analysis using antibodies. The immunoblots were developed with the enhanced chemiluminescence system (ECL, Amersham Pharmacia Biotech.).
Abbreviations ROS, reactive oxygen species; DCm, mitochondrial membrane potential; TGF b1, transforming growth factor b1; HGF, hepatocyte growth factor; SA-b-gal, senescence-associated b-galactosidase; DMEM, Dulbecco's modified Eagle's medium; FBS, fetal bovine serum; PBS, phosphate-buffered saline; DNP, 2,4-dinitrophenol; TMPD, tetramethyl-p-phenylene diamine; PARP, poly (ADP-ribose) polymerase; NAC, N-acetylcysteine; DPI, diphenyleneiodonium chloride; EMT, epithelial-to-mesenchymal transdifferentiation.
